Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schneerson

Showing results (81-90 of 208) with videos related to

Pageof 21
Sort By:
The Pediatric Infectious Disease Journal|October 1, 1993
Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccineJ B Robbins, M Pittman, B Trollfors, et al.
Developments in Biological Standardization|December 17, 1998
Measurement of human serum IgG antibodies or a surrogate is sufficient to standardize (predict efficacy) vaccinesJ B Robbins, R Schneerson, S C Szu, et al.
Vaccine|August 30, 2005
Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?Daniel M Stein, John Robbins, Mark A Miller, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccineBo A Claesson, Birger Trollfors, Teresa Lagergård, et al.
Vox Sanguinis|January 1, 1986
IgG subclass deficienciesL A Hanson, J Björkander, J B Robbins, et al.
Carbohydrate Research|May 24, 2011
Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme diseaseVince Pozsgay, Joanna Kubler-Kielb, Bruce Coxon, et al.
Infection and Immunity|September 1, 1992
Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxinR Schneerson, L Levi, J B Robbins, et al.
Vaccine|February 13, 2007
The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTPJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
Infection and Immunity|August 1, 1990
Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12F polysaccharide and diphtheria toxoidC Lue, S J Prince, A Fattom, et al.
The Journal of Experimental Medicine|November 1, 1987
Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animalsS C Szu, A L Stone, J D Robbins, et al.
Pageof 21

Showing results (81-90 of 208) with videos related to

Sort By:
Pageof 21
The Pediatric Infectious Disease Journal|October 1, 1993
Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccineJ B Robbins, M Pittman, B Trollfors, et al.
Developments in Biological Standardization|December 17, 1998
Measurement of human serum IgG antibodies or a surrogate is sufficient to standardize (predict efficacy) vaccinesJ B Robbins, R Schneerson, S C Szu, et al.
Vaccine|August 30, 2005
Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?Daniel M Stein, John Robbins, Mark A Miller, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccineBo A Claesson, Birger Trollfors, Teresa Lagergård, et al.
Vox Sanguinis|January 1, 1986
IgG subclass deficienciesL A Hanson, J Björkander, J B Robbins, et al.
Carbohydrate Research|May 24, 2011
Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme diseaseVince Pozsgay, Joanna Kubler-Kielb, Bruce Coxon, et al.
Infection and Immunity|September 1, 1992
Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxinR Schneerson, L Levi, J B Robbins, et al.
Vaccine|February 13, 2007
The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTPJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
Infection and Immunity|August 1, 1990
Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12F polysaccharide and diphtheria toxoidC Lue, S J Prince, A Fattom, et al.
The Journal of Experimental Medicine|November 1, 1987
Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animalsS C Szu, A L Stone, J D Robbins, et al.
Pageof 21